Pharmacognosy intro
Ocimum basilicum L., Lamiaceae. Leaves and flowering tops. Common names include sweet basil and garden basil. Distinct from holy basil (Ocimum tenuiflorum), which has a separate adaptogenic profile. Multiple chemotypes exist with different dominant compounds. Key active compounds include linalool (7-45% depending on chemotype), eugenol, methyl chavicol/estragole (up to 87% in certain chemotypes), 1,8-cineole, geraniol, rosmarinic acid, anthocyanins (in purple varieties), and beta-caryophyllene. Chemotype selection is pharmacologically critical: the linalool chemotype is preferred for therapeutic use, while the estragole-dominant chemotype carries genotoxicity concerns at concentrated doses. Sweet basil essential oil demonstrates confirmed GABAergic mechanism. CNS depression at all tested doses, including reduction of spontaneous activity, ptosis, ataxia, sedation, prolonged sleeping time, and decreased sleep latency, was reversed by flumazenil, proving GABA-A receptor-benzodiazepine complex interaction. Linalool, eugenol, and rosmarinic acid drive anxiolytic and antidepressant effects through GABAergic transmission modulation, antioxidative pathways, and BDNF level enhancement. Beta-caryophyllene acts as a CB2 cannabinoid receptor agonist providing anti-inflammatory signaling through the endocannabinoid system. Anti-inflammatory activity in neural tissue proceeds through reduction of TLR4, TNF-alpha, and IL-1beta expression in the hippocampus, with decreased MDA levels and increased total antioxidant capacity. A randomized single-blinded clinical trial with 60 major depressive disorder patients found basil syrup for 4 weeks produced significant reductions in HAM-A anxiety and BDI depression scores compared to placebo (p<0.05) (Talaei et al., 2025). This is the most direct human psychiatric evidence. Antimicrobial testing showed MIC against S. aureus of 45 ug/mL and B. subtilis of 40 ug/mL, with ROS scavenging IC50 of 12-17 ug/mL (Shirazi et al., 2014). Preclinical neuroprotective findings include amelioration of autistic-like behaviors induced by maternal separation stress in mice at 20-60 mg/kg, with improved spatial and social memory and reduced hippocampal neuroinflammation (Amini-Khoei et al., 2024). Network pharmacology identified dibutyl phthalate from O. basilicum as a compound for Alzheimer's treatment via AKT/GSK-3beta pathway regulation, reducing LDH and ROS in amyloid-beta-induced neuronal injury (Simayi et al., 2022).